investors.merck.com investors.merck.com

investors.merck.com

Merck & Co., Inc. - Investors

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. What We're Working On. Business Development and Licensing. Research and Development News. From Service to Science. How Will You Invent the Future? Merck R...

http://investors.merck.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.MERCK.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 14 reviews
5 star
3
4 star
5
3 star
4
2 star
0
1 star
2

Hey there! Start your review of investors.merck.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

2.2 seconds

FAVICON PREVIEW

  • investors.merck.com

    16x16

CONTACTS AT INVESTORS.MERCK.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Merck & Co., Inc. - Investors | investors.merck.com Reviews
<META>
DESCRIPTION
Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. What We're Working On. Business Development and Licensing. Research and Development News. From Service to Science. How Will You Invent the Future? Merck R...
<META>
KEYWORDS
1 worldwide
2 about us
3 corporate responsibility
4 leadership
5 board of directors
6 executive committee
7 our work
8 how we operate
9 code of conduct
10 compliance
CONTENT
Page content here
KEYWORDS ON
PAGE
worldwide,about us,corporate responsibility,leadership,board of directors,executive committee,our work,how we operate,code of conduct,compliance,transparency and privacy,internet privacy policy,cookie privacy commitment,cross border policy,diversity,ebola
SERVER
DOSarrest
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Merck & Co., Inc. - Investors | investors.merck.com Reviews

https://investors.merck.com

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. What We're Working On. Business Development and Licensing. Research and Development News. From Service to Science. How Will You Invent the Future? Merck R...

INTERNAL PAGES

investors.merck.com investors.merck.com
1

Merck & Co., Inc. - Incyte and Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA® (pembrolizumab)

http://investors.merck.com/news/press-release-details/2017/Incyte-and-Merck-to-Advance-Clinical-Development-Program-Investigating-the-Combination-of-Epacadostat-with-KEYTRUDA-pembrolizumab/default.aspx

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. The MRL Postdoctoral Fellow Program. What We're Working On. Discover Where Our Research Happens. Business Development and Licensing. Stock Quote and Chart.

2

Merck & Co., Inc. - Investor Resources - Information Request

http://investors.merck.com/investor-resources/information-request/default.aspx

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. The MRL Postdoctoral Fellow Program. What We're Working On. Discover Where Our Research Happens. Business Development and Licensing. Stock Quote and Chart.

3

Merck & Co., Inc. - Financials - Quarterly Reports

http://investors.merck.com/financials/quarterly-reports/default.aspx

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. The MRL Postdoctoral Fellow Program. What We're Working On. Discover Where Our Research Happens. Business Development and Licensing. Stock Quote and Chart.

4

Merck & Co., Inc. - Stock Info - Stock Splits

http://investors.merck.com/stock-info/stock-splits/default.aspx

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. The MRL Postdoctoral Fellow Program. What We're Working On. Discover Where Our Research Happens. Business Development and Licensing. Stock Quote and Chart.

5

Merck & Co., Inc. - Financials - Annual Reports & Proxy

http://investors.merck.com/financials/annual-reports-and-proxy/default.aspx

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. The MRL Postdoctoral Fellow Program. What We're Working On. Discover Where Our Research Happens. Business Development and Licensing. Stock Quote and Chart.

UPGRADE TO PREMIUM TO VIEW 12 MORE

TOTAL PAGES IN THIS WEBSITE

17

SOCIAL ENGAGEMENT



OTHER SITES

investors.medicinova.com investors.medicinova.com

Investor Home | MediciNova

160; 0.07. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. There are currently no events scheduled. There are currently no items available. Sign up to receive email alerts whenever Medicinova Inc posts new information to the site. Just enter your email address and click Submit.

investors.medivation.com investors.medivation.com

Medivation | Driven by science. Focused on life.

The investor pages that follow are your resource for financial information about Medivation, Inc. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. August 06, 2015. Medivation Reports Second Quarter 2015 Financial Results. July 16, 2015.

investors.medivation.net investors.medivation.net

medivation.net

investors.mekonomen.se investors.mekonomen.se

Mekonomen - Mekonomen

investors.memc.com investors.memc.com

Overview | SunEdison

Financial and SEC Filings. Global Ethics and Compliance. Code of Business Conduct. Gifts and Entertainment Policy. In Supply Chain Act Statement. Financial and SEC Filings. Global Ethics and Compliance. Code of Business Conduct. Gifts and Entertainment Policy. In Supply Chain Act Statement. Q2 2015 SunEdison, Inc and TerraForm Power, Inc. Earnings Conference Call. 160;at 8:00 am ET. Q2 2015 Earnings Conference Call Presentation. August 06, 2015. August 06, 2015. 08/06/15 8:00 am ET. 160; 2.12.

investors.merck.com investors.merck.com

Merck & Co., Inc. - Investors

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. What We're Working On. Business Development and Licensing. Research and Development News. From Service to Science. How Will You Invent the Future? Merck R...

investors.meritagehomes.com investors.meritagehomes.com

IRWeblink

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.

investors.meritor.com investors.meritor.com

Meritor, Inc. - Investors - Investors

Brakes and Safety Systems. Data collected 08/01/15 - 08/08/15. Q3 2015 Meritor, Inc. Earnings Conference Call. 160;at 9:00 am ET. Q3 2015 Meritor, Inc. Earnings Conference Call. Wednesday, July 29, 2015 . 9:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Meritor ChampTruck World Series Brings Thrill of Big-Rig Racing to Virginia International Raceway. Meritor Expands its Euclid Clutch Portfolio to Include Self-Adjusting 15.5" Model. 160; 0.04. Minimum 20 minute delay.

investors.merrimackpharma.com investors.merrimackpharma.com

Investors | Merrimack Pharmaceuticals

Skip to main navigation. Stock Quote and Chart. Stock Quote and Chart. March 12, 2018. Merrimack Provides Business Update and Reports 2017 Financial Results. Strengthened the randomized Phase 2 SHERLOC study evaluating MM-121 in non-small cell lung cancer by expanding enrollment from 80 to 100 patients - - Dosed the first patient in randomized Phase 2 SHERBOC study evaluating MM-121 in metastatic breast cancer - - Announced the formation of a new. March 12, 2018. March 5, 2018. Cambridge, MA 02139.

investors.merunetworks.com investors.merunetworks.com

Investor Relations - Meru Networks

K-12 / Primary Education. Presentations and Investor Events. Quarterly Earnings and Financial Releases. Annual Reports and Proxies. Meru Networks Investor Relations. Sunnyvale, CA 94089. Jun 23, 2015. Meru Networks' K-12 Wi-Fi Subscription XPress Cloud Service Offers Simplicity to the Unsung IT Heroes of Education. May 27, 2015. Fortinet Announces Agreement to Acquire Meru Networks. View all financial releases ». May 4, 2015 at 5:00 PM ET. Meru Networks Q1 2015 Earnings Call. Mar 10, 2015.

investors.metalsusa.com investors.metalsusa.com

Metals USA Investor Relations

Metals USA is a provider of processed carbon steel, stainless steel, aluminum, red metals and manufactured metal components. On April 12, 2013, we were acquired by Reliance Steel and Aluminum Company ("Reliance"). Reliance is the largest metal service center company in North America and a leading provider of value-added metal processing and inventory management services. Metals USA Announces Stockholder Approval Of Merger Agreement With Reliance Steel and Aluminum Co.